Abstract:Objective— By excreting cellular cholesterol to apolipoprotein A-I, ATP-binding cassette transporter A1 (ABCA1) mediates the biogenesis of high-density lipoprotein in hepatocytes and prevents foam cell formation from macrophages. We recently showed that cell surface–resident ABCA1 (csABCA1) undergoes ubiquitination and later lysosomal degradation through the endosomal sorting complex required for transport system. Herein, we investigated the relevance of this degradation pathway to the turnover of csABCA1 in hypercholesterolemia. Approach and Results— Immunoprecipitation and cell surface-biotinylation studies with HepG2 cells and mouse peritoneal macrophages showed that the ubiquitination level and degradation of csABCA1 were facilitated by treatment with a liver X receptor (LXR) agonist and acetylated low-density lipoprotein. The effects of an LXR agonist and acetylated low-density lipoprotein on the degradation of csABCA1 were repressed completely by treatment with bafilomycin, an inhibitor of lysosomal degradation, and by depletion of tumor susceptibility gene 101, a major component of endosomal sorting complex required for transport-I. RNAi analysis indicated that LXRβ inhibited the accelerated lysosomal degradation of csABCA1 by the LXR agonist, regardless of its transcriptional activity. Cell surface coimmunoprecipitation with COS1 cells expressing extracellularly hemagglutinin-tagged ABCA1 showed that LXRβ interacted with csABCA1 and inhibited the ubiquitination of csABCA1. Immunoprecipitates with anti-ABCA1 antibodies from the liver plasma membranes showed less LXRβ and a higher ubiquitination level of ABCA1 in high-fat diet–fed mice than in normal chow-fed mice. Conclusions— Under conditions of high cellular cholesterol content, csABCA1 became susceptible to ubiquitination by dissociation of LXRβ from csABCA1, which facilitated the lysosomal degradation of csABCA1 through the endosomal sorting complex required for transport system.

Cyclosporin A Traps ABCA1 at the Plasma Membrane and Inhibits ABCA1-mediated Lipid Efflux to Apolipoprotein A-I.

The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.

Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation

Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats

Cyclosporin A does not cause hyperlipidemia in kidney graft recipients

The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8+ T cells

Cyclosporine Stimulates the Renal Epithelial Sodium Channel by Elevating Cholesterol

Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions

Cyclosporin A Impairs Dendritic Cell Migration by Regulating Chemokine Receptor Expression and Inhibiting Cyclooxygenase-2 Expression

Influence of CYP3A and ABCB1 Polymorphisms on Cyclosporine Concentrations in Renal Transplant Recipients.

Cyclosporin A affects the bioavailability of ginkgolic acids via inhibition of P-gp and BCRP.

Cyclosporine A Inhibits Breast Cancer Cell Growth By Downregulating The Expression Of Pyruvate Kinase Subtype M2

Cellular Cholesterol Accumulation Facilitates Ubiquitination and Lysosomal Degradation of Cell Surface–Resident ABCA1

Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt.

Rapid degradation of ABCA1 protein following cAMP withdrawal and treatment with PKA inhibitor suggests ABCA1 is a short-lived protein primarily regulated at the transcriptional level

An innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor alpha and NFATc2

A Potential Side Effect of Cyclosporin A: Inhibition of CD4+CD25+ Regulatory T Cells in Mice

Targeting Extracellular Cyclophilin A via an Albumin‐Binding Cyclosporine A Analogue

Cyclosporin A Up-regulates B7-DC Expression on Dendritic Cells in an IL-4-dependent MannerIn Vitro, Which is Associated with Decreased Allostimulatory Capacity of Dendritic Cells

Longitudinal study of cyclosporine and lipids in patients undergoing bone marrow transplantation

The Influence of Cyclosporin A on Lymphocyte Attenuator Expression